UPDATE 1-AstraZeneca bets on gene editing for broad range of new drugs
January 29, 2015 at 02:35 AM EST
* Builds on in-house CRISPR programme at drugmaker (Adds details on collaborations, scientific background)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.